Filing Details

Accession Number:
0001181431-14-009803
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-27 20:36:58
Reporting Period:
2014-02-25
Filing Date:
2014-02-27
Accepted Time:
2014-02-27 20:36:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1276591 Hansen Medical Inc HNSN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222357 J Peter Mariani C/O Hansen Medical, Inc.
800 East Middlefield Road
Mountain View CA 94043
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-25 12,533 $2.30 43,435 No 4 F Direct
Common Stock Disposition 2014-02-26 43,435 $2.30 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2014-02-25 125,000 $0.00 125,000 $2.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,000 2024-02-25 No 4 A Direct
Footnotes
  1. Shares withheld to satisfy withholding obligations in connection with the settlement of vested performance-based stock units. The vesting of the applicable performance based stock units was reported on the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on February 13, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.27 to $2.33, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. 25% of the option shares will vest and become exercisable on February 25, 2015 and the remaining option shares will vest and become exercisable ratably over the 36 months thereafter, subject to continuous service by the Reporting Person through each such date.